M

02629

Mirxes Holding

12.410

+2.980+23.69%
Suspension09:20 05/29 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE15.800/12.410
TODAY RANGE12.380-17.080
VOL62.61M
MARKET CAP3.70B
52 WEEK RANGE12.280-77.300
AVG VOL (3M)4.80M
% TURNOVER0.00%
TURNOVER800.00M
P/E (TTM)-6.185
% RANGE30.21%
EPS(TTM)-2.006
P/E(FORWARD)-7.577
P/B4.514
BVPS2.749
DIVIDEND--
P/S22.252
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.70B
SHARES OUTSTANDING298.23M
NEXT EARNINGS--
FREE FLOAT298.23M
LOT SIZE100
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

昊海生物科技

06826

+0.05%
18.230

藥明康德

02359

+3.82%
130.300

H

Hangzhou Tigermed Consulting

03347

+2.72%
30.940

昭衍新藥

06127

+1.35%
17.990

康龍化成

03759

+0.75%
17.520

方達控股

01521

-2.78%
0.700

01035

--

中國醫療集團

08225

0.00%
0.124

00233

--

C

China Regenerative Medicine International

08572

0.00%
0.010

邁博藥業-B

02181

-1.25%
0.395

維亞生物

01873

+0.80%
1.260

中國再生醫學

08158

+8.11%
0.400

東曜藥業-B

01875

+0.73%
4.140

華領醫藥-B

02552

-3.31%
2.630

微創腦科學

02172

+2.68%
9.200

康寧傑瑞製藥-B

09966

-8.90%
8.290

中國抗體-B

03681

+3.33%
1.240

樂普生物

02157

+4.41%
4.260

加科思-B

01167

+4.70%
4.900

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.